Lemonade is down nearly 10% on the week to $70.14, yet its short sellers are adding positions and its CFO just sold $5.8 million of stock — a combination that sharpens the stakes ahead of the July 29 earnings print.
The most telling development is in the insider tape. CFO Timothy Bixby sold 73,000 shares on July 7 at $79.18, collecting $5.78 million — the largest insider transaction in at least several months and one rated low on significance only because it appears routine in structure. The sale came as the stock was still trading well above $77, and it followed smaller routine sells from other executives in early July and June. Net insider activity over the past 90 days is technically positive at roughly 85,000 shares, but that net is distorted by earlier director purchases; the recent flow has been entirely one-directional. A CFO trimming this aggressively into a rally heading into a high-stakes print is the kind of signal institutional readers tend to flag.
Short positioning reinforces the caution. Short interest has climbed to 14.82% of the free float — up roughly 5% on the week and continuing a slow build from around 10.3 million shares in mid-June to 11.1 million now. That is a genuinely elevated level for a stock that has already rallied 22% over the past month. Borrow, however, remains cheap at 0.42%, down sharply from last week, and availability is loose at 428% — meaning for every share already borrowed there are more than four available to lend. The borrow market is not under pressure. Short sellers are not paying to carry this trade, and there is no mechanical squeeze risk at current positioning. The setup is bears adding at a high price on easy terms, not a crowded trade at risk of unwind.
Options positioning sits just above neutral. The put/call ratio of 0.64 is running modestly above its 20-day average of 0.62 — less than one standard deviation — and well below its 52-week peak of 0.74. There is no elevated demand for downside protection in the options market that would corroborate the short-side conviction. The two signals point in different directions: shorts are building, but options traders are not especially defensive.
The Street is uneasy but not uniformly negative. Piper Sandler raised its target to $75 from $62 on July 15, maintaining Neutral — a meaningful lift that still leaves the target slightly below the current price. That follows Morgan Stanley's July 8 downgrade from Overweight to Equal-Weight at $75, which was noted in last week's note and remains the defining analyst action of the past fortnight. The consensus stands at hold, with five analysts there and one at Outperform against a persistent Underperform from Keefe, Bruyette & Woods (target $48). The mean price target of $62.44 now sits 11% below where the stock is trading — an unusual inversion that reflects how far the rally has outrun analyst models. Bulls point to the AI-driven platform, Q1 beats, and raised 2026 guidance. Bears flag stock-based compensation costs and the distance to positive EBITDA. The ORTEX short score of 64.5 places LMND in firmly bearish territory by composite signal.
Earnings history adds texture without comfort. The last two meaningful prints — April 29 and June 3 — produced next-day moves of -13.9% and -11.2% respectively, with the five-day drift after each negative as well. Only the April 30 print was positive on the day, and that was followed by a five-day decline. Peer ROOT fell 2.9% on the week while FG and LNC both managed gains above 5%, suggesting the weakness in LMND is stock-specific rather than sector-driven.
With two weeks to the July 29 report, the question is whether the stock can hold ground between $70 and $75 — the zone where both Piper Sandler and Morgan Stanley have planted their targets — or whether the combination of insider selling, rebuilding short interest, and a historically punishing earnings reaction pattern keeps sellers in control.
See the live data behind this article on ORTEX.
Open LMND on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
